<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee1803a19ee">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">2001-01-29</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>39 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:GAO-01-183</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-01-183</identifier>
<identifier type="local">P0b002ee1803a19ee</identifier>
<identifier type="former package identifier">f:d01183</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-24</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-GAO-01-183</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-GAO-01-183</accessId>
 <reportNumber>GAO-01-183</reportNumber>
 <subject>Veterans benefits</subject>
 <subject>Veterans hospitals</subject>
 <subject>Standards and standardization</subject>
 <subject>Drugs</subject>
 <subject>Health services administration</subject>
 <subject>Health care services</subject>
 <subject>Internal controls</subject>
 <identifier>VA Veterans Integrated Service Network</identifier>
 <type>Letter Report</type>
 <law congress="106" isPrivate="false" number="117"></law>
 <congReport congress="105" number="610" type="H"></congReport>
</extension>
<titleInfo>
 <title>VA Drug Formulary: Better Oversight Is Required, but</title>
</titleInfo>
<abstract>Over the past three years, the Department of Veterans Affairs (VA) has
made significant progress in establishing its national drug formulary,
which has generally met with prescriber acceptance. GAO reported that
veterans are generally receiving the drugs they need and that veterans
rarely register complaints concerning prescription drugs. VA has not
provided sufficient oversight, however, to ensure that the Veterans
Integrated Service Networks (VISN) and medical centers comply with
formulary policies and that the flexibility given to them does not
unduly compromise VA&apos;s goal of formulary standardization. Contrary to VA
formulary policy, some facilities omitted national formulary drugs or
modified the closed drug classes. While adding a limited number of drugs
to supplement the national formulary is permitted, as more drugs are
added by VISNs, formulary differences among facilities are likely to
become more pronounced, decreasing formulary standardization. While VA
recognizes the trade-off between local flexibility and standardization,
it lacks criteria for determining the appropriateness of adding drugs to
supplement the national formulary and therefore may not be able to
determine whether the decrease in standardization is acceptable.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-01-183/html/GAOREPORTS-GAO-01-183.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-01-183/pdf/GAOREPORTS-GAO-01-183.pdf</url>
</location>
<identifier type="preferred citation">GAO-01-183</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-01-183</url>
</location>
<note>Letter Report</note>
<extension>
 <searchTitle>GAO-01-183; VA Drug Formulary: Better Oversight Is Required, but;
            </searchTitle>
</extension>
<subject>
 <topic>Veterans benefits</topic>
 <topic>Veterans hospitals</topic>
 <topic>Standards and standardization</topic>
 <topic>Drugs</topic>
 <topic>Health services administration</topic>
 <topic>Health care services</topic>
 <topic>Internal controls</topic>
 <topic>VA Veterans Integrated Service Network</topic>
</subject>
<relatedItem type="isReferencedBy">
 <titleInfo>
  <title>United States Public Law 117 (106th Congress)</title>
</titleInfo>
 <identifier type="public law citation">Public Law 106-117</identifier>
</relatedItem>
<relatedItem type="isReferencedBy">
 <titleInfo>
  <title>United States House Report 610 (105th Congress)</title>
</titleInfo>
 <identifier type="congressional report citation">H. Rept. 105-610</identifier>
</relatedItem>
</mods>